Attenuation of reserpine-induced catalepsy by melatonin and the role of the opioid system.
Several reports have indicated that melatonin influences motor activity in animals and humans. Melatonin has been reported to attenuate the rigidity and tremor of Parkinson's disease. Some of the behavioral effects (e.g., analgesic and anticonvulsant properties) of melatonin have been reported to be mediated through interactions with the endogenous opioid peptides. We investigated the effect of melatonin on reserpine-induced catalepsy in the rat and, additionally, examined whether this effect is modified by opioid peptides. Melatonin was found to attenuate markedly the duration of reserpine-induced catalepsy. These effects were potentiated by administration of the opiate agonist nalbuphine hydrochloride, while naloxone partially reversed the catalepsy reducing effect of melatonin. These findings suggest that the motor effects of melatonin may involve critical interactions with opioid peptides, and support the postulated reciprocal interactions between melatonin and opioid peptides that previously have been demonstrated for the analgesic and anticonvulsant properties of melatonin.
Sandyk
R
R
New York State Psychiatric Institute, NY 10032.
Mukherjee
S
S
D000818:Animals; D002375:Catalepsy / Q000139:chemically induced* / Q000378:metabolism; D004723:Endorphins / Q000494:pharmacology*; D005260:Female; D008550:Melatonin / Q000494:pharmacology*; D009266:Nalbuphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012110:Reserpine / Q000494:pharmacology*
D004723:Endorphins; D009270:Naloxone; D012110:Reserpine; D008550:Melatonin; D009266:Nalbuphine